# A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin

> **NCT02141906** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Hepatocellular Cancer

## Interventions

- **OTHER:** Oncozene-DEB-TACE

## Key facts

- **NCT ID:** NCT02141906
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-21
- **Primary completion:** 2018-06-22
- **Final completion:** 2022-05-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141906, "A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02141906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*